(Q38738762)

6 September 2017

title

Implications of plant glycans in the development of innovative vaccines (English)

1 reference

6 September 2017

author name string

Sergio Rosales-Mendoza

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890067%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Eva L Decker

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890067%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

18 February 2016

1 reference

Expert Review of Vaccines

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890067%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890067%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890067%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

915-925

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26890067%20AND%20SRC:MED&resulttype=core&format=json

Immunity to viruses: learning from successful human vaccines

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Vaccines based on structure-based design provide protection against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Carbohydrate-based immune adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Chemistry and biology of oligovalent β-(1→2)-linked oligomannosides: new insights into carbohydrate-based adjuvants in immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Emerging principles for the therapeutic exploitation of glycosylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Carbohydrate-based cancer vaccines: target cancer with sugar bullets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Cancer vaccines and carbohydrate epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Safety of Typhim Vi vaccine in a postmarketing observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Neisseria meningitidis: biology, microbiology, and epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Global epidemiology of meningococcal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006-2014).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

The love-hate relationship between bacterial polysaccharides and the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Starch granules as a vehicle for the oral administration of immobilized antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Phase 1 clinical study with Bioneedles, a delivery platform for biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Carbohydrate-Based Vaccines: An Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Carbohydrate-based vaccines: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Recombinant plants provide a new approach to the production of bacterial polysaccharide for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Protein-glycan interactions in the control of innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Glycotherapy: new advances inspire a reemergence of glycans in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Pattern recognition receptors and control of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Alternative delivery of a thermostable inactivated polio vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Bioneedles as vaccine carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Pseudomonas cellulose-binding domains mediate their effects by increasing enzyme substrate proximity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Comparative characterization of complete and truncated forms of Lactobacillus amylovorus alpha-amylase and role of the C-terminal direct repeats in raw-starch binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

The starch-binding domain as a tool for recombinant protein purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

A novel antigen-carrier system: the Mycobacterium tuberculosis Acr protein carried by raw starch microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Engineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Rice seed for delivery of vaccines to gut mucosal immune tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Soybean seeds: a practical host for the production of functional subunit vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Chemical biology approaches to designing defined carbohydrate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Engineering chloroplasts for high-level foreign protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Current status of viral expression systems in plants and perspectives for oral vaccines development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Moss-made pharmaceuticals: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Concentrated protein body product derived from rice endosperm as an oral tolerogen for allergen-specific immunotherapy--a new mucosal vaccine formulation against Japanese cedar pollen allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Tibetan plateau gets wired up for monsoon prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Clinical care of two patients with Ebola virus disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

US signs contract with ZMapp maker to accelerate development of the Ebola drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Engineering of sialylated mucin-type O-glycosylation in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Induction of budding on chloronemata and caulonemata of the moss, Physcomitrella patens, using isopentenyladenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Image analysis supported moss cell disruption in photo-bioreactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Enhancing the growth of Physcomitrella patens by combination of monochromatic red and blue light - a kinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Large-scale analysis of 73 329 physcomitrella plants transformed with different gene disruption libraries: production parameters and mutant phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Stable transformation of the moss Physcomitrella patens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

An improved and highly standardised transformation procedure allows efficient production of single and multiple targeted gene-knockouts in a moss, Physcomitrella patens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Glyco-engineering of moss lacking plant-specific sugar residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

A gene responsible for prolyl-hydroxylation of moss-produced recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Production of biologically active recombinant human factor H in Physcomitrella

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

The potential of Physcomitrella patens as a platform for the production of plant-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Current challenges in plant cell walls: editorial overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Comparative structure and biomechanics of plant primary and secondary cell walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

The cellulose synthase (CESA) gene superfamily of the moss Physcomitrella patens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

High-throughput mapping of cell-wall polymers within and between plants using novel microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Demonstration of UDP-glucose dehydrogenase activity in cell extracts of Escherichia coli expressing the pneumococcal cap3A gene required for the synthesis of type 3 capsular polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Metabolic engineering of plants: the role of membrane transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Definition of the bacterial N-glycosylation site consensus sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Production of glycoprotein vaccines in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Carrot cells: a pioneering platform for biopharmaceuticals production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

From gene to harvest: insights into upstream process development for the GMP production of a monoclonal antibody in transgenic tobacco plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Robust Stimulation of Humoral and Cellular Immune Responses following Vaccination with Antigen-Loaded β-Glucan Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987

Polypotency of the immunomodulatory effect of pectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1155987